Nelumbo nucifera GAERTN., the family of Nelumbonaceae, is a perennial, rhizomatous, aquatic plant distributed throughout Asia, including India, China, and Egypt. The plant is comprised of: membranous, peltate, orbicular, and concave leaves; nut-contained and ovoid fruits; black, hard, and ovoid seeds; nodal roots. In Korea, China and India, various parts of N. nucifera have been used in foodstuffs and traditional medicine for the treatment of diarrhea, gastritis, insomnia, nervous prostration and as a haemostatic.
have been reported from the leaves of N. nucifera. In addition, Mukherjee et al. reported that N. nucifera rhizomes possessed diverse bioactivities, including antibacterial, 10) antidiarrhoeal, 11) diuretic, 12) antifungal, 13) antipyretic, 14) anti-inflammatory, 15) and antidiabetic. 16, 17) Additionally, the rhizomes have been reported to exhibit antihypertensive 18) and memory enhancing activities. 19) Regarding the seeds, several reports exist on their hepatoprotective, 20) antioxidant, 21) antifertility, 22) and antipyretic activities, 23) as well as their inhibitory effects on pulmonary fibrosis. 24) Recently, N. nucifera semen extract was reported to improve memory in rats with scopolamine-induced dementia through the induction of choline acetyltransferase expression and inhibition of acetylcholinesterase (AChE). 25) Even though individual parts of this plant have been the target of distinct biological and pharmacological research, there are limited studies of the stamens, with the exception of research focusing upon the antioxidant and rat lens aldose reductase (RLAR) inhibition [26] [27] [28] and anti-allergic activities 29) attributed to the flavonoids. Alzheimer's disease (AD) is a neurodegenerative disease and the most frequent and predominant cause of dementia in the elderly, provoking progressive cognitive decline, psychobehavior disturbances, memory loss, the presence of senile plaques, neurofibrillary tangles, and a decrease in cholinergic transmission. 30, 31) Although the pathogenesis of AD is complicated and involved in numerous pathways, two major hypotheses are currently under consideration regarding the molecular mechanism, the cholinergic hypothesis and the amyloid cascade hypothesis. Thus, the focus herein is upon inhibitors of select cholinesterases (ChEs) to alleviate cholinergic deficits and improve neurotransmission and b-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1; aspartyl protease, b-secretase, and memapsin2) inhibitors to preclude formation and accumulation of amyloid b peptide (Ab). Pursuant to this, both could then be established as viable therapeutic targets for AD. [31] [32] [33] [34] Given that numerous promising pharmaceuticals and nutraceuticals are constantly isolated from effective natural products, and that a previous study from this lab indicated potent antioxidant and RLAR inhibitory activities of N. nucifera stamens, this plant was chosen for ongoing investigations into anti-AD activities. The present work deals with the isolation and characterization of a new b-cyclogeraniol diglycoside (5), and four known compounds: cycloartenol (1); p-hydroxybenzoic acid (2); vanilloloside (3); 5Ј-Omethyladenosine (4). Furthermore, the inhibitory activities of 1-5 toward ChEs, including AChE and butyrylcholinesterase (BChE), and BACE1 were evaluated. tionless enhancement by polarization transfer (DEPT) spectra were determined using a JEOL JNM ECP-400 spectrometer (Tokyo, Japan) at 400 MHz for 1 H and 100 MHz for 13 C. The chemical shifts were referenced to residual solvent peaks (CDCl 3 , DMSO-d 6 , and pyridine-d 5 ). The EI-MS data were collected on a GC-MS QP-5050A spectrometer (Shimadzu, Kyoto, Japan). The LR and HR FAB-MS data were assessed using a JEOL JMS-HX110/110A spectrometer (Tokyo, Japan). Column chromatography was conducted using silica (Si) Extraction, Fractionation, and Isolation The stamens (3.4 kg) of N. nucifera were refluxed in methanol (MeOH) for 3 h (9 lϫ3). The total filtrate was then concentrated to dryness in vacuo at 40°C to render the MeOH extract (560 g). This extract was suspended in distilled water (H 2 O) and then successively partitioned between methylene chloride (CH 2 Cl 2 ), ethyl acetate (EtOAc), and n-butanol (n-BuOH), to yield CH 2 Cl 2 (330 g), EtOAc (20 g), n-BuOH (66 g) fractions, respectively, as well as an H 2 O residue (140 g). A portion of the n-BuOH fraction (26.6 g) was first chromatographed over a Si gel column (100 mm i.d.ϫ80 cm), using a mixed solvent system of EtOAc-MeOH (20 : 1→10 : 1→5 : 1→0 : 1, gradient) to afford thirteen fractions (BF01-BF13). Repeated column chromatography of fraction 1 (BF01, 1.5 g) was performed over a Si gel column (20 mm i.d.ϫ20 cm) with n-hexaneEtOAc (15 : 1→0 : 1, gradient) to obtain cycloartenol (1, 25 mg) and p-hydroxybenzoic acid (2, 13 mg). Repeated column chromatography of combined fractions 2 and 3 (BF02/03, 9 g) was performed over a Si gel column (60 mm i. 
MATERIALS AND METHODS

General Experimental Procedures
2,
37) 3, 38) and 4 39) were characterized by comparison with published data (Fig. 1) .
Nuciferoside ( 5 mlϫ3 times) . The residual water layer was neutralized with Amberlite MB-3 and dried to obtain a residue. The residue was dissolved in pyridine (1 ml), and 0.1 M L-cysteine methyl ester hydrochloride in pyridine (2 ml) was added. The mixture was maintained at 60°C for 1.5 h. After drying the reaction mixture in vacuo, the residue was trimethylsilylated with hexamethyldisilazane-trimethylchlorosilane (0.1 ml) at 60°C for 1 h. The mixture was partitioned between hexane and H 2 O (0.3 ml each), and the hexane extract was analyzed by GC (column, DB-1, 0.25 mm i.d.ϫ30 m; column temperature, 50-230°C, 15°C/min, 230°C for 18 min; carrier gas, He). The sugar derivatives obtained exhibited a retention time of 21.30 min, identified with that of authentic D-glucose. Under these conditions, a derivative of L-glucose displayed a retention time of 22.00 min. 40) In Vitro ChEs Enzyme Assay The inhibitory activities of the ChEs were measured using the spectrophotometric method developed by Ellman et al. 41) ACh and BCh were used as the substrates to assay the inhibitions of AChE and BChE, respectively. The reaction mixture contained: 140 ml of sodium phosphate buffer (pH 8.0); 20 ml of tested sample solution (final concentration (f.c.) 100 mM for the compounds); and 20 ml of either AChE or BChE solution, which were mixed and incubated for 15 min at room temperature. All tested samples and the positive control (galanthamine) were dissolved in 10% analytical grade dimethyl sulfoxide (DMSO). The reactions were started with the addition of 10 ml of DTNB and 10 ml of either ACh or BCh, respectively. The hydrolysis of ACh or BCh was monitored by following the formation of the yellow 5-thio-2-nitrobenzoate anion at 412 nm for 15 min, which resulted from the reaction of DTNB with thiocholine, released by the enzymatic hydrolysis of either ACh or BCh, respectively. All reactions were performed in triplicate and recorded in 96-well microplates, using VERSA max (Molecular Devices, Sunnyvale, CA, U.S.A.). Percent inhibition was calculated from (1ϪS/E)ϫ 100, where E and S were the respective enzyme activities without and with the tested sample, respectively. The ChEs inhibitory activity of each sample was expressed in terms of the IC 50 value (mM required to inhibit the hydrolysis of the substrate, ACh or BCh, by 50%), as calculated from the logdose inhibition curve.
Kinetic Parameters of 1-3 and 5 in AChE Inhibition
In order to determine the inhibition mechanism, AChE inhibition was evaluated by monitoring the effects of different concentrations of substrates (0.6, 0.3, and 0.1 mM for 1, 3, and 5; 0.6, 0.4, and 0.2 mM for 2), respectively. The reaction mixture consisted of the aforementioned ChEs assay method: 140 ml of sodium phosphate buffer (pH 8.0); 20 ml of tested sample solution (f.c. 100 mM for the compounds); 20 ml of either AChE solution, mixed and incubated for 15 min at room temperature. The reactions were initiated upon addition of 10 ml of DTNB and 10 ml of either ACh. All tested samples and the positive control (galanthamine) were dissolved in 10% analytical grade DMSO. Inhibition constants (K i ) were determined by interpretation of the Dixon plot, where the value of the x-axis implies ϪK i . 42) In Vitro BACE1 Enzyme Assay The assay was carried out according to the supplied manual with select modifications. Briefly, a reaction solution which consists of 10 ml of assay buffer (50 mM sodium acetate, pH 4.5), 10 ml of BACE1 (1.0 U/ml), 10 ml of the substrate (750 nM Rh-EVNL-DAEFK-Quencher in 50 mM, ammonium bicarbonate), and 10 ml of the tested samples (f.c. 100 mM for compounds) dissolved in 10% DMSO was incubated for 60 min at 25°C in the dark. The proteolysis of two fluorophores (Rh-EVNL-DAEFK-Quencher) by BACE1 was monitored by the formation of the fluorescent donor (Rh-EVNL), which increases in fluorescence wavelengths at 530-545 nm (excitation) and 570-590 nm (emission), respectively. Fluorescence was measured with a microplate spectrofluorometer (Spectralmax Gemini XPS, Molecular devices, Sunnyvale, CA, U.S.A.). The mixture was irradiated at 545 nm and the emission intensity was recorded at 585 nm. Percent inhibition (%) was obtained by the following equation: % inhibitionϭ[1Ϫ(S 60 Ϫ S 0 )/(C 60 ϪC 0 )]ϫ100, where C 60 was the fluorescence of the control (enzyme, buffer, substrate) after 60 min of incubation, C 0 was the initial fluorescence of the control, S 60 was the fluorescence of the tested samples (enzyme, sample solution, substrate) after 60 min of incubation, and S 0 was the initial fluorescence of the tested samples. To allow for the quenching effect of the samples, the sample solution was added to reaction mixture C, and any reduction in fluorescence by the sample was then investigated. The BACE1 inhibitory activity of each sample was expressed in terms of the IC 50 value (mM required to inhibit the proteolysis of the substrate; BACE1, by 50%), as calculated from the log-dose inhibition curve. Quercetin was used as a positive control.
Statistics The Kruskal-Wallis test and the Mann-Whitney U test were used to determine the statistical significance of differences between values for various experimental and control groups. Data were expressed as the meanϮS.E.M. in triplicate.
RESULTS AND DISCUSSION
Recently, the rhizome and semen of N. nucifera have been reported to possess enhancing effects on memory and learning 19) and anti-amnesic effects in rats with scopolamineinduced dementia, respectively. 25) To the best of the author's knowledge, N. nucifera stamens have yet to be studied in the context of anti-AD activity. In addition, phytochemical researches on polar fractions such as n-BuOH are limited. Therefore, focus was upon characterization of other intriguing components from the N. nucifera stamens, with antiAlzheimer effects evaluated via AChE, BChE, and BACE1 inhibitory assays.
Likewise, a previous study revealed that the rhizome and semens of N. nucifera showed AChE inhibition. 19, 25, 43) In this lab's preliminary study, the MeOH extract of N. nucifera stamens exerted good ChEs inhibition: IC 50 values of 40.81 mg/ml for AChE; 61.61 mg/ml for BChE. Thus, bioactive-guided fractionation of the extract was performed to obtain the CH 2 Cl 2 , EtOAc, n-BuOH, and H 2 O fractions. Although all bioactive data were not shown, the EtOAc and nBuOH fractions exhibited slightly higher AChE inhibitory activities over other fractions, with respective IC 50 values of 33.58 and 24.73 mg/ml. Since the EtOAc fraction was reported to contain numerous flavonoids, 26, 27) and it is well known that these flavonoids might attribute to their ChEs inhibition, 44, 45) detailed phytochemical investigations and anti-AD studies on the n-BuOH fraction were carried out; the n-BuOH fraction also harbors AChE activities and lacks substantial research. Repeated column chromatography of the n-BuOH fraction was accomplished to yield a new b-cyclogeraniol diglycoside (5), along with four known components 1-4 (Fig. 1) . Through comparison of published NMR and EI-MS data, the structures of the known compounds were identified as cycloartenol (1), 35, 36) p-hydroxybenzoic acid (2), 37) vanilloloside (3), 38) and 5Ј-O-methyladenosine (4). 39) This is the first report of isolation of these four, known compounds 1-4 from this plant.
Compound 5 was obtained as a white amorphous powder. The positive HR FAB-MS of 5 afforded a quasi-molecular ion peak at m/z 501.2308 [MϩNa] ϩ , with a molecular formula of C 22 H 38 O 11 . The 1 H-NMR spectrum (Table 1) 1.11, 1.12 , and 1.77 (each 3H, s), assigned to a b-cyclogeraniol. 46) This observation was further confirmed by 13 C-NMR spectrometric assignments (Table 1) 50 , mM) are expressed as the meanϮS.E.M. of triple experiments. c) SI: selectivity index (BChE/AChE). e) Galanthamine and f) quercetin were reference compounds in the ChEs and BACE1 assays. The anti-Alzheimer effects of 1-5 from N. nucifera stamens were evaluated via the AChE, BChE, and BACE1 inhibition assays. As shown in Table 2 Table 2) . Although some research has been performed on ChEs inhibitory activities of monoterpenes [48] [49] [50] and tetracyclic steroidal alkaloids, 51, 52) this is the first reports on the ChEs inhibitory activities of 1-3 and 5.
In order to determine the type of AChE inhibition, kinetic analysis of 1-3 and 5 was carried out by monitoring the effects of three different concentrations of ACh as a substrate (0.6, 0.3, and 0.1 mM for 1, 3, and 5; 0.6, 0.4 and 0.2 mM for 2) by Dixon plots. As demonstrated in Figs. 2A-2D , the manner of inhibition of 1-3 and 5 was noncompetitive with K i values of 15.71, 25.44, 7.76, and 5.76 mM, respectively, as compared with a competitive inhibitor, galanthamine. 53) However, 1-5 showed no BACE1 inhibition up to 100 mM.
In conclusion, a new b-cyclogeraniol diglycoside, nuciferoside (5), along with four known compounds, cycloartenol (1), p-hydroxybenzoic acid (2), vanilloloside (3), and 5Ј-Omethyladenosine (4), were isolated from the n-BuOH fraction of N. nucifera stamens for the first time. To further delineate their potential regarding prevention and treatment of AD, AChE, BChE, and BACE1 inhibition assays were carried out. As a result, 1-3 and 5 showed good and noncompetitive AChE inhibitory activities while 1, 2, and 5 exhibited BChE inhibitory activities. According to the ChEs assay results, the authors contend that 1-3 and 5 are possible ChEs inhibitors with potential for treatment of AD. Therefore, N. nucifera stamens-derived compounds could potentially exert their anti-Alzheimer effects primarily as AChE inhibitors rather than BACE1 inhibitors.
